News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Stephen V Liu: Update from the Phase 2 PHAROS Study
Stephen Liu/LinkedIn
Jun 6, 2025, 09:57

Stephen V Liu: Update from the Phase 2 PHAROS Study

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:

“Update from the Phase 2 PHAROS Study of Encorafenib and Binimetinib in BRAF V600E NSCLC JTO & JTO CRR.

As 1L therapy, RR 75%, DOR 40m, PFS 30m, 3y OS rate 53%. In previously treated, RR 46%, DOR 16.7m, PFS 9.3m, OS 22.7m, 3y OS 29%.”

Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC‒A Brief Report.

Authors: Gregory J. Riely, Myung-Ju Ahn, Jeffrey M. Clarke, Ibiayi Dagogo-Jack, Raymond Esper, Enriqueta Felip, Francesco Gelsomino, Jonathan W. Goldman, Maen Hussein, Melissa Johnson, Kristen A. Marrone, Daniel Morgensztern, Ernest Nadal, Marcelo V. Negrao, Michael Offin, Mariano Provencio, Suresh S. Ramalingam, Logan Roof, Rachel E. Sanborn, Egbert F. Smit, Anne Tsao, Tiziana Usari, Ann Alcasid, Keith Wilner, Svitlana Tonkovyd, Xiaosong Zhang, and Bruce E. Johnson.

You can read the full article on Journal of Thoracic Oncology.

Stephen V Liu: Update from the Phase 2 PHAROS Study

More posts featuring Stephen V Liu.

Ann Alcasid Anne Tsao binimetinib BRAF Bruce E Johnson cancer Daniel Morgensztern Egbert F. Smit encorafenib Enriqueta Felip Ernest Nadal fight against cancer Francesco Gelsomino Georgetown University Global fight against cancer Gregory J. Riely Ibiayi Dagogo-Jack Jeffrey M. Clarke Jonathan W. Goldman JTO & JTO Keith Wilner Kristen A. Marrone Logan Roof Maen Hussein Marcelo V. Negrao Mariano Provencio Melissa Johnson Michael Offin Myung-Ju Ahn NSCLC OncoDaily Oncology PHAROS Study Rachel E. Sanborn Raymond Esper Stephen V Liu Suresh S. Ramalingam Svitlana Tonkovyd Tiziana Usari V600E Xiaosong Zhang
Special Coverage
Insight
Aug 28, 2025, 18:07
Tony Marchand: Excited to Announce our Article on Hematopoietic Stem Cell Regulation
Voices
Aug 28, 2025, 18:05
City Cancer Challenge Highlights Locally-Driven Breast Cancer Action Plans
Science
Aug 28, 2025, 17:59
Italiano Antoine Highlights Study on Turning "Cold" Tumors Immune-Active
Insight
Aug 28, 2025, 17:56
Johanna Olweus: TCR Targeting b-catenin Shows Promise in Patient-Derived Models
Voices
Aug 28, 2025, 17:54
Triparna Sen: Registration Is Open for the LungSphere Leadership Exchange
Voices
Aug 28, 2025, 17:54
Pat Garcia-Gonzalez: Discussing CML and Access to Cancer Care at SOHO 2025
Societies
Aug 28, 2025, 17:47
Join the SIOP Fun(d) Run and Walk to Benefit Children with Cancer - SIOP
Blog Posts
Aug 28, 2025, 17:44
Supporting Léman Hope Foundation Through a Swimming Challenge - UICC
Societies
Aug 28, 2025, 17:38
CCI Europe’s Carina Schneider Speaks at Expo2025 Osaka on Cancer Advocacy
Voices
Aug 28, 2025, 17:30
CancerWorld Features Jayasree K. Iyer on the Fight for Equitable Cancer Care
Blog Posts
Aug 28, 2025, 17:20
Celia Diez de los Rios: Understanding Fears and Trust Issues in Cancer Information
Voices
Aug 28, 2025, 17:19
LUNGevity Foundation Pays Tribute to Lung Cancer Advocate Bonnie J. Addario